Evidence map›Paper›PMID 35935242›Full record

ArticleFrontiers in microbiology2022

SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13.

Bo Zhang, Yan Xie, Zhaoling Lan, Dayu Li, Junjie Tian, Qintao Zhang, Hongji Tian, Jiali Yang, Xinnan Zhou, Shuyi Qiu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bo ZhangCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Yan XieSchool of Public Health, Zunyi Medical University, Zunyi, China.
Zhaoling LanCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Dayu LiCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Junjie TianCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Qintao ZhangCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Hongji TianCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Jiali YangCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Xinnan ZhouCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Shuyi QiuKey Laboratory of Plant Resource Conservation and Germplasm Innovation in Mountainous Region (Ministry of Education), College of Life Sciences/Institute of Agro-bioengineering, Guizhou University, Guiyang, China.
Keyu LuCollege of Basic Medicine, Zunyi Medical University, Zunyi, China.
Yang LiuSchool of Public Health, Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CNGuizhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the world and has had a devastating impact on health and economy. The biochemical characterization of SARS-CoV-2 proteins is important for drug design and development. In this study, we discovered that the SARS-CoV-2 nucleocapsid protein can melt double-stranded DNA (dsDNA) in the 5'-3' direction, similar to SARS-CoV-2 nonstructural protein 13. However, the unwinding activity of SARS-CoV-2 nucleocapsid protein was found to be more than 22 times weaker than that of SARS-CoV-2 nonstructural protein 13, and the melting process was independent of nucleoside triphosphates and Mg

Indexed as

helicaseNsp13nucleocapsid proteinSARS-CoV-2unwinding

Identifiers

PMID35935242
PMCPMC9354549
OpenAlexW4286698058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.